Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

6
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

5
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
5
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

8
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
8
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

10
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
10
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

10.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Healing and Amputation Trajectories in Diabetic Foot Ulcers: Predictive Power of Wound Area and Duration and Sample-Size Implications From the Diabetic Foot Consortium.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026
Same author

Unbiased distance correlation with sample-size-aware confidence bounds for comparative omics network analysis.

Frontiers in bioinformatics·2026
Same author

A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the Bladder.

Urology·2026
Same author

Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA Profiling.

Clinical genitourinary cancer·2026
Same author

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

bioRxiv : the preprint server for biology·2026
Same author

Please Tell Me It Is Only a Nightmare-The Proposed Dismantling of the United States Federal Research Infrastructure.

Diabetes care·2026

Related Experiment Video

Updated: Apr 22, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

8.0K

Altered sphingoid base profiles in type 1 compared to type 2 diabetes.

Nancy Wei, Jessica Pan, Rodica Pop-Busui

  • 1MGH Neuroscience Center, Department of Neurology, Harvard Medical School, 55 Fruit Street ACC 708, Boston, MA 02114, USA. feichler@partners.org.

Lipids in Health and Disease
|October 13, 2014
PubMed
Summary

1-deoxysphingolipids (1-deoxySL) are elevated in type 2 diabetes but not type 1 diabetes. This suggests 1-deoxySL are linked to metabolic changes specific to type 2 diabetes, not just high blood sugar.

More Related Videos

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

9.0K
A Model of Chronic Nutrient Infusion in the Rat
08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

12.2K

Related Experiment Videos

Last Updated: Apr 22, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

8.0K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

9.0K
A Model of Chronic Nutrient Infusion in the Rat
08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

12.2K

Area of Science:

  • Metabolic research
  • Lipidomics
  • Endocrinology

Background:

  • Sphingolipids are implicated in insulin resistance and diabetes.
  • Previous studies found elevated 1-deoxysphingolipids (1-deoxySL) in metabolic syndrome and type 2 diabetes (T2DM).
  • The status of 1-deoxySL in type 1 diabetes (T1DM) remained unclear.

Purpose of the Study:

  • To investigate whether 1-deoxySL levels are elevated in individuals with T1DM.
  • To compare 1-deoxySL levels in T1DM, T2DM, and healthy controls.
  • To determine the association of 1-deoxySL with hyperglycemia versus other metabolic changes.

Main Methods:

  • Plasma samples from T1DM (N=27), T2DM (N=30), and healthy controls (N=23) were analyzed.
  • Long chain base profiles were determined using liquid chromatography-mass spectrometry (LC-MS) after headgroup hydrolysis.
  • Quantification of 1-deoxysphingolipids (1-deoxySL) was performed.

Main Results:

  • 1-deoxySL levels were significantly higher in T2DM patients compared to controls.
  • No significant difference in 1-deoxySL levels was observed between T1DM patients and healthy controls.
  • Elevated 1-deoxySL levels were specifically associated with T2DM, not T1DM.

Conclusions:

  • 1-deoxySL elevation is not a direct consequence of hyperglycemia.
  • The increase in 1-deoxySL is specifically linked to metabolic alterations characteristic of T2DM, such as elevated triglyceride levels.
  • These findings differentiate the role of 1-deoxySL in T1DM versus T2DM.